Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "68d51d9a26579f4bc195771a",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ",
"description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ",
"price": 263.0,
"discountamount": 80.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2182,
"imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-25T10:46:50.098Z",
"updatedon": "2025-10-02T11:20:20.402Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIMITERIS MV1 0.2",
"category": "",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6891f29bfb7044dfb2d43adf",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "MAGRAL 160",
"description": "MAGRAL 160 is a pharmaceutical medication containing megestrol acetate 160 mg, a synthetic progestin known for its potent antineoplastic and appetite-stimulating properties. This drug is primarily prescribed to manage significant health challenges such as unexplained weight loss, anorexia, and cachexia, especially in patients suffering from chronic conditions like cancer or AIDS. Additionally, megestrol acetate functions as a hormone therapy agent employed in the treatment of certain hormone-sensitive malignancies. Its dual action both supports tumor management and improves patients' nutritional status by stimulating appetite and promoting weight gain, thereby enhancing overall quality of life. The drug is regarded as a crucial option in oncology and palliative care for managing complex conditions related to hormone-dependent cancers and severe wasting syndromes.\n\nWhat is MAGRAL 160?\nMAGRAL 160 is an oral medication formulated with megestrol acetate 160 mg, a synthetic progestin hormone derivative. It works primarily by modulating hormone receptors and altering hormone levels that influence the growth of hormone-responsive tumors such as breast and endometrial cancers. Apart from its antineoplastic action, it stimulates appetite by acting on the hypothalamic centers responsible for hunger, helping patients suffering from severe weight loss regain a healthy appetite and weight.\n\nUses of MAGRAL 160\n\nTo treat hormone-dependent cancers, specifically advanced breast cancer and endometrial cancer.\n\nTo stimulate appetite and promote weight gain in patients experiencing anorexia, cachexia, or unexplained severe weight loss related to chronic illnesses like cancer or AIDS.\n\nTo manage wasting syndromes that lead to malnutrition and significant weight loss.\n\nTo serve as an antineoplastic agent in hormone-sensitive malignancies.\n\nIn short, MAGRAL 160 is primarily used to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy.\n\nSide Effects of MAGRAL 160\n\nWeight gain (often desirable but can be excessive)\n\nFluid retention and edema (swelling)\n\nNausea and vomiting\n\nDiarrhea or constipation\n\nVaginal bleeding or spotting in women\n\nFatigue, weakness, and insomnia\n\nHeadache and dizziness\n\nIncreased risk of blood clots (deep vein thrombosis or pulmonary embolism)\n\nHormonal imbalances, such as decreased sex hormone levels, which can lead to sexual dysfunction or bone density loss\n\nAllergic reactions including rash or itching\n\nPatients should report severe or unusual symptoms, especially signs of blood clots such as limb swelling, chest pain, or sudden shortness of breath, immediately to their healthcare provider.\n\nPrecautions before Using MAGRAL 160\n\nInform your doctor if you are pregnant, breastfeeding, or planning to conceive as MAGRAL 160 is contraindicated in pregnancy.\n\nDisclose any history of blood clots, cardiovascular diseases, liver or kidney impairment.\n\nPatients with diabetes should monitor blood sugar closely as megestrol acetate may cause hyperglycemia.\n\nAvoid sudden discontinuation without medical advice to prevent potential hormonal withdrawal effects.\n\nRegular monitoring is required, including hormone levels and blood tests, to assess efficacy and safety during treatment.\n\nUse cautiously in patients at risk for deep vein thrombosis or pulmonary embolism due to increased clotting risks.\n\nDrug Interactions: What Drugs Interact with MAGRAL 160?\n\nCYP3A4 enzyme inducers (e.g., rifampin, phenytoin) may reduce the effectiveness of megestrol acetate by increasing its metabolism.\n\nConcurrent use with blood thinners (anticoagulants) requires careful monitoring as MAGRAL 160 might influence clotting parameters.\n\nCombining with drugs that affect hormonal pathways, such as other hormonal therapies or corticosteroids, may alter treatment outcomes.\n\nInteractions with diabetes medications might necessitate dose adjustment due to potential effects on blood sugar control.\n\nCareful medical supervision is necessary when used with immunosuppressants or other chemotherapy agents to avoid additive side effects or altered drug levels.\n\nConclusion\nMAGRAL 160, containing megestrol acetate 160 mg, is a clinically validated medication widely used to manage complex conditions such as hormone-dependent cancers as well as severe weight loss due to anorexia and cachexia. Its unique ability to act both as an antineoplastic agent and an appetite stimulant makes it invaluable in improving patient outcomes, nutritional status, and overall quality of life. Patients prescribed MAGRAL 160 should adhere strictly to their healthcare provider’s instructions and report any adverse effects promptly. This medication should always be used under medical supervision to ensure optimal benefits and minimize risks.",
"price": 810.0,
"discountamount": 243.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2156,
"imageuri": "https://productimages.withfloats.com/actual/6891f2a0115b51057b971998.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6891f2a0115b51057b971998.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-08-05T12:01:31.195Z",
"updatedon": "2025-08-05T12:01:31.195Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/magral-160/2156",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "megestrol acetate 160 mg",
"category": "Gynaecology",
"tags": [
"megestrol acetate 160 mg"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "683d8fd4990bc014137527ef",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "STERIMMUNE HEPA PROTEIN POWDER",
"description": "STERIMMUNE HEPA PROTEIN POWDER is a scientifically formulated nutritional supplement designed to support overall wellness, energy, and liver function. Enriched with essential multivitamins, vital minerals, high-quality protein, and choline, this powder provides a balanced solution to meet daily nutritional needs. Ideal for individuals recovering from illness, with weakened immunity, or seeking a daily health boost, it contributes to enhanced vitality and supports organ health—particularly liver health.\n\nKey Ingredients\nMultivitamins: Includes a broad spectrum of vitamins such as A, B-complex, C, D, and E that support immune health, metabolism, vision, and energy production.\n\nMulti Minerals: Essential minerals like calcium, magnesium, zinc, selenium, and iron help in strengthening bones, oxygen transport, antioxidant defense, and enzymatic functions.\n\nProtein: High-quality protein helps in muscle repair, tissue regeneration, and maintaining lean body mass.\n\nCholine: An essential nutrient that plays a critical role in liver function, brain development, nerve function, and fat metabolism.\n\nKey Benefits\nProvides complete nutritional support for the body’s daily needs\n\nPromotes healthy immune system function\n\nSupports liver health and helps improve fat metabolism\n\nEnhances muscle recovery and energy production\n\nImproves cognitive function and memory through the action of choline\n\nSupports antioxidant activity to combat oxidative stress\n\nIdeal for recovery from chronic illness or surgery\n\nSuitable for all age groups including growing children, adults, and the elderly\n\nHow Does It Work?\nSTERIMMUNE HEPA PROTEIN POWDER works by replenishing essential nutrients that may be deficient due to poor diet, illness, or increased physiological demand.\n\nThe multivitamins and minerals help activate numerous biological processes including enzyme function, energy release, and immune defense.\n\nProtein aids in muscle growth, cellular repair, and maintaining body structure.\n\nCholine supports liver detoxification, helps prevent fat accumulation in the liver, and improves neurotransmitter activity.\n\nThe synergistic effect of these ingredients ensures optimal absorption and utilization, keeping the body nourished and resilient.\n\nDirections for Use\nMix one or two tablespoons (approx. 15–30g) of the powder with 200 ml of lukewarm milk or water.\n\nStir well until completely dissolved and consume immediately.\n\nTake once or twice daily, or as directed by a healthcare professional.\n\nCan be consumed with breakfast or between meals for best results.\n\nSide Effects\nSTERIMMUNE HEPA PROTEIN POWDER is generally well tolerated when taken as directed. However, mild side effects may occur in sensitive individuals such as:\n\nBloating or gas due to protein digestion\n\nMild nausea if taken on an empty stomach\n\nAllergic reaction in individuals sensitive to any ingredient (consult label)\n\nAlways consult your physician before starting any supplement, especially if you are pregnant, breastfeeding, or have a chronic medical condition.\n\n",
"price": 427.0,
"discountamount": 129.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"200 ml",
"pregnant breastfeeding",
"individuals sensitive",
"gas due",
"sensitive individuals",
"healthcare professional",
"consume immediately",
"completely dissolved",
"water stir",
"lukewarm milk",
"resilient directions",
"body nourished",
"utilization keeping",
"synergistic effect",
"deficient due",
"age groups",
"surgery suitable",
"critical role",
"broad spectrum",
"enhanced vitality",
"weakened immunity",
"individuals recovering",
"balanced solution",
"wellness energy",
"bodys daily",
"chronic illness",
"essential nutrient",
"ingredient consult label",
"poor diet illness",
"complete nutritional support",
"liver function enriched",
"daily health boost",
"meet daily nutritional",
"chronic medical condition",
"replenishing essential nutrients",
"mild side effects",
"tablespoons approx 1530g",
"improves neurotransmitter activity",
"increased physiological demand",
"growing children adults"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2129,
"imageuri": "https://productimages.withfloats.com/actual/683d8fd9ff3655f5a866e74c.png",
"tileimageuri": "https://productimages.withfloats.com/tile/683d8fd9ff3655f5a866e74c.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-06-02T11:49:40.984Z",
"updatedon": "2025-06-02T11:52:09.316Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/sterimmune-hepa-protein-powder/2129",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "MULTIVITAMIN, MULTI MINERAL PROTEIN POWDER WITH CHOLINE",
"category": "GENERAL RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "680f67727d2a43891e570ff9",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "BENOTIAMINE PLUS CAPSULES",
"description": "Step into a new era of nutritional wellness with BENOTIAMINE PLUS CAPSULES, a specially crafted formula designed to support nerve function, enhance metabolic health, and strengthen the body’s natural antioxidant defenses. Powered by a synergistic blend of Benfotiamine, Alpha Lipoic Acid, Inositol, Mecobalamin, Folic Acid, Chromium, and Selenium, these capsules deliver comprehensive protection and nourishment, especially for individuals dealing with nerve discomfort, diabetes-related complications, and oxidative stress.\n\nKey Ingredients\nBenfotiamine: A highly bioavailable derivative of Vitamin B1 that penetrates nerve cells effectively, shielding them from glucose-induced damage.\n\nAlpha Lipoic Acid: A universal antioxidant that revitalizes other antioxidants, supports nerve health, and improves insulin sensitivity.\n\nInositol: A key molecule involved in nerve signaling and healthy cell function.\n\nMecobalamin (Methylcobalamin): The neurologically active form of Vitamin B12 crucial for nerve repair and regeneration.\n\nFolic Acid: Essential for DNA synthesis, cardiovascular protection, and nerve health maintenance.\n\nChromium: Supports glucose metabolism and enhances insulin action, promoting balanced blood sugar levels.\n\nSelenium: A powerful antioxidant that defends cells against oxidative injury and supports immune system resilience.\n\nKey Benefits\nSupports Nerve Regeneration: Promotes healthy nerve structure and function, reducing symptoms of neuropathy.\n\nStrengthens Antioxidant Shield: Fights harmful free radicals to protect nerves and vital tissues from oxidative stress.\n\nBoosts Metabolic Health: Aids in effective carbohydrate metabolism and energy production.\n\nRegulates Blood Sugar: Helps maintain healthy blood glucose levels, crucial for diabetics and pre-diabetics.\n\nEnhances Cardiovascular and Immune Health: Folic Acid and Selenium work synergistically to promote heart and immune system performance.\n\nOverall Vitality Boost: Supports energy levels, mood balance, and overall cellular health.\n\nHow Does It Work?\nBENOTIAMINE PLUS CAPSULES work by targeting the root causes of nerve and metabolic dysfunction:\n\nBenfotiamine protects nerve cells from high-glucose damage by preventing the formation of harmful advanced glycation end-products (AGEs).\n\nAlpha Lipoic Acid improves nerve blood flow and revives exhausted antioxidant defenses.\n\nMecobalamin and Inositol actively contribute to nerve repair and optimal signal transmission.\n\nChromium assists in the management of blood sugar, reducing oxidative stress linked to hyperglycemia.\n\nSelenium provides cellular defense, reducing inflammation and oxidative injury.\n\nThis multi-targeted action supports comprehensive nerve, metabolic, and antioxidant health, ensuring stronger protection and faster recovery.\n\nDirections for Use\nRecommended Dose: Take one capsule once or twice daily or as advised by your physician.\n\nAdministration: Best taken after meals with a glass of water.\n\nConsistency: For maximum benefit, it is important to take the capsules regularly and maintain a healthy diet and lifestyle alongside supplementation.\n\nSide Effects\nBENOTIAMINE PLUS CAPSULES are generally safe and well-tolerated. Rarely, some users may experience:\n\nMild gastrointestinal upset (such as bloating or diarrhea)\n\nAllergic reactions (rash, itching, or redness)\n\nLightheadedness or headache (very uncommon)\n\nAlways consult your healthcare provider if you experience any unexpected symptoms, or before starting if you have underlying health conditions.",
"price": 229.0,
"discountamount": 69.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"capsules regularly",
"work benotiamine",
"nerve repair",
"nerve signaling",
"capsules work",
"healthcare provider",
"redness lightheadedness",
"welltolerated rarely",
"generally safe",
"healthy diet",
"maximum benefit",
"water consistency",
"physician administration",
"recommended dose",
"hyperglycemia selenium",
"highglucose damage",
"promote heart",
"vital tissues",
"protect nerves",
"oxidative injury",
"defends cells",
"powerful antioxidant",
"universal antioxidant",
"individuals dealing",
"synergistic blend",
"nutritional wellness",
"unexpected symptoms",
"cellular health",
"vitamin b1",
"selenium work synergistically",
"underlying health conditions",
"function reducing symptoms",
"vitamin b12 crucial",
"faster recovery directions",
"inositol actively contribute",
"immune system performance",
"prediabetics enhances cardiovascular",
"effective carbohydrate metabolism",
"neurologically active form",
"key molecule involved",
"highly bioavailable derivative"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2092,
"imageuri": "https://productimages.withfloats.com/actual/680f6774222caea0261d3d90.png",
"tileimageuri": "https://productimages.withfloats.com/tile/680f6774222caea0261d3d90.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-04-28T11:33:06.87Z",
"updatedon": "2025-04-28T11:33:06.87Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/benotiamine-plus-capsules/2092",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Benfotiamine, Alpha Lipoic Acid, Inositol, Mecobalamin, Folic Acid, Chromium and Selenium Capsules",
"category": "DIABETIC RANGE",
"tags": [
"Benfotiamine",
"Alpha Lipoic Acid",
"Inositol",
"Mecobalamin",
"Folic Acid",
"Chromium and Selenium Capsules"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "66d83ad4ed345980e0fca5c5",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Voglibose (0.3mg), Metformin (500mg), Gliclazide (80mg)",
"description": "GLICLAGLAZE TRIO 0.3 \nVoglibose (0.3mg), Metformin (500mg), Gliclazide (80mg)\nGLICLAGLAZE TRIO 0.3 is a powerful combination medication designed to manage and control type 2 diabetes. It is formulated with three active ingredients: Voglibose, Metformin, and Gliclazide. This unique combination helps to regulate blood sugar levels effectively, providing a comprehensive approach to diabetes management. GLICLAGLAZE TRIO 0.3 is particularly useful for patients who require a multifaceted treatment strategy to keep their blood glucose levels in check.\n\n \n\nKey Benefits:\n \n\nEffective Blood Sugar Control: The combination of Voglibose, Metformin, and Gliclazide offers a synergistic effect, providing comprehensive control over blood sugar levels.\nPrevents Post-Meal Sugar Spikes: Voglibose helps in delaying glucose absorption, reducing the risk of hyperglycemia after meals.\nImproved Insulin Sensitivity: Metformin enhances the body's response to insulin, ensuring better glucose management.\nEnhanced Insulin Secretion: Gliclazide helps in stimulating insulin release from the pancreas, making it easier to maintain stable blood sugar levels.\n \n\nHow Does It Work?\n \n\nGLICLAGLAZE TRIO 0.3 works through a multi-pronged approach to manage diabetes. Voglibose slows down the absorption of carbohydrates in the gut, which helps to prevent rapid increases in blood sugar levels after meals. Metformin reduces the liver's glucose production and improves insulin sensitivity, ensuring better glucose uptake and utilization. Gliclazide stimulates the pancreas to release insulin, aiding in the reduction of blood glucose levels.\n\n \n\nDirections for Use:\n \n\nTake GLICLAGLAZE TRIO 0.3 as prescribed by your healthcare provider. It is typically taken before meals to maximize its effectiveness in controlling postprandial blood sugar spikes. Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. Your doctor will determine the appropriate dosage and frequency based on your individual health needs.\n\n \n\nSide Effects:\n \n\nLike all medications, GLICLAGLAZE TRIO 0.3 may cause some side effects. Common side effects include gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain. Hypoglycemia (low blood sugar) may occur, especially if you skip meals or engage in intense physical activity. Other possible side effects include dizziness, headache, and fatigue. If you experience any severe side effects or allergic reactions, seek medical attention immediately.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n",
"price": 185.0,
"discountamount": 56.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"Key Benefits",
"abdominal pain",
"glucose uptake",
"type 2 diabetes",
"rapid increases",
"insulin release",
"low blood sugar",
"GLICLAGLAZE TRIO",
"medical attention",
"glucose absorption",
"allergic reactions",
"appropriate dosage",
"synergistic effect",
"unique combination",
"glucose production",
"glucose management",
"diabetes management",
"healthcare provider",
"severe side effects",
"Common side effects",
"blood glucose levels",
"comprehensive control",
"multi-pronged approach",
"comprehensive approach",
"Post-Meal Sugar Spikes",
"individual health needs",
"three active ingredients",
"intense physical activity",
"stable blood sugar levels",
"Enhanced Insulin Secretion",
"Other possible side effects",
"Improved Insulin Sensitivity",
"gastrointestinal disturbances",
"Effective Blood Sugar Control",
"powerful combination medication",
"multifaceted treatment strategy",
"postprandial blood sugar spikes"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1962,
"imageuri": "https://productimages.withfloats.com/actual/66d83afac7293b3595ec4ea6.jpeg",
"tileimageuri": "https://productimages.withfloats.com/tile/66d83afac7293b3595ec4ea6.jpeg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-09-04T10:47:48.369Z",
"updatedon": "2024-09-04T10:47:48.369Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/voglibose-0-3mg-metformin-500mg-gliclazide-80mg-/1962",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLICLAGLAZE TRIO 0.3 ",
"category": "DIABETIC RANGE",
"tags": null,
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6662cb8e161afa2274ff6309",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VOGLIGOLD 0.3 ",
"description": "VOGLIGOLD 0.3 \nVoglibose (0.3mg)\nIntroduction to VOGLIGOLD 0.3\nVOGLIGOLD 0.3 is an oral medication designed to help manage type 2 diabetes mellitus by controlling blood sugar levels. It contains Voglibose, an alpha-glucosidase inhibitor that works by slowing the digestion and absorption of carbohydrates in the intestines. This mechanism helps prevent spikes in blood sugar levels after meals. VOGLIGOLD 0.3 is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Component and Mechanism of Action\nVoglibose 0.3mg\nVoglibose is a potent alpha-glucosidase inhibitor. It functions by inhibiting the alpha-glucosidase enzyme in the small intestine, which is responsible for breaking down complex carbohydrates into simple sugars. By inhibiting this enzyme, Voglibose slows down the conversion of carbohydrates into glucose, thereby reducing the postprandial (after-meal) rise in blood sugar levels.\n\nSlows Carbohydrate Absorption: By delaying the absorption of glucose, Voglibose helps to smooth out the postprandial blood glucose peaks.\nReduces Postprandial Hyperglycemia: It specifically targets the blood sugar spikes that occur after meals, making it an effective treatment for controlling postprandial hyperglycemia.\nBenefits of VOGLIGOLD 0.3\nEffective Postprandial Blood Sugar Control\nManages After-Meal Blood Sugar Levels: VOGLIGOLD 0.3 helps to manage and reduce the rise in blood sugar levels that occur after meals.\nComplementary Therapy: It can be used in combination with other antidiabetic medications such as metformin, sulfonylureas, or insulin to provide comprehensive glycemic control.\nAdditional Health Benefits\nWeight Neutral: Voglibose is generally weight neutral, making it a favorable option for patients concerned about weight gain associated with other diabetes medications.\nLow Risk of Hypoglycemia: When used alone, Voglibose has a low risk of causing hypoglycemia (low blood sugar), as it does not increase insulin secretion directly.\nHow to Use VOGLIGOLD 0.3\nDosage and Administration\nRecommended Dosage: The typical dosage of VOGLIGOLD 0.3 is one tablet taken three times a day, just before meals.\nAdministration: Take the tablet whole with a glass of water, just before starting your meal. This timing ensures that the medication works effectively by inhibiting the enzyme responsible for carbohydrate digestion.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VOGLIGOLD 0.3 regularly at the same times each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is important to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/st-gliptin-dapa-100-10-134075",
"price": 119.0,
"discountamount": 35.7,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"dapa",
"rise",
"diet",
"Order",
"water",
"EMAIL",
"meals",
"glass",
"option",
"timing",
"Action",
"adults",
"gliptin",
"patients",
"exercise",
"readings",
"Low Risk",
"metformin",
"VOGLIGOLD",
"Voglibose",
"mechanism",
"Guidelines",
"conversion",
"same times",
"intestines",
"one tablet",
"Optimal Use",
"weight gain",
"combination",
"information",
"Adjustments",
"Introduction",
"Hypoglycemia",
"sterisonline",
"best results",
"sterispharma",
"sulfonylureas",
"CALL/WHATSAPP",
"simple sugars",
"Key Component",
"treatment plan",
"typical dosage",
"Administration",
"Consistent Use",
"Weight Neutral",
"low blood sugar",
"small intestine",
"oral medication",
"insulin secretion",
"Regular monitoring",
"Recommended Dosage",
"blood sugar spikes",
"effective treatment",
"healthcare provider",
"complex carbohydrates",
"Complementary Therapy",
"carbohydrate digestion",
"Meal Blood Sugar Levels",
"Carbohydrate Absorption",
"alpha-glucosidase enzyme",
"type 2 diabetes mellitus",
"Postprandial Hyperglycemia",
"Additional Health Benefits",
"other diabetes medications",
"comprehensive glycemic control",
"other antidiabetic medications",
"postprandial blood glucose peaks",
"potent alpha-glucosidase inhibitor",
"Effective Postprandial Blood Sugar Control"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1518,
"imageuri": "https://productimages.withfloats.com/actual/667d3145422dd0be26724c0b.png",
"tileimageuri": "https://productimages.withfloats.com/tile/667d3145422dd0be26724c0b.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-07T08:57:50.904Z",
"updatedon": "2024-06-27T09:30:42.497Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/vogligold-0-3-/1518",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VOGLIGOLD 0.3 ",
"category": "DIABETIC RANGE",
"tags": [
"voglibose 0.3mg price",
"voglibose 0.3mg dosage",
"voglibose 0.3mg brands in india"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6662c935a743fd2358222332",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VOGLIGOLD 0.2 ",
"description": "VOGLIGOLD 0.2 \nVoglibose (0.2mg)\nIntroduction to VOGLIGOLD 0.2\nVOGLIGOLD 0.2 is a medication designed to manage type 2 diabetes mellitus by helping to control blood sugar levels. It contains Voglibose, an alpha-glucosidase inhibitor, which works by slowing down the digestion and absorption of carbohydrates from the intestines. This action helps to prevent spikes in blood sugar levels after meals. VOGLIGOLD 0.2 is used in conjunction with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Component and Mechanism of Action\nVoglibose 0.2mg\nVoglibose is a potent alpha-glucosidase inhibitor. It works by inhibiting the alpha-glucosidase enzyme in the small intestine, which is responsible for breaking down complex carbohydrates into simple sugars. By inhibiting this enzyme, Voglibose slows down the conversion of carbohydrates into glucose, thereby reducing the postprandial (after-meal) rise in blood sugar levels.\n\nSlows Carbohydrate Absorption: By delaying the absorption of glucose, Voglibose helps to smooth out the postprandial blood glucose peaks.\nReduces Postprandial Hyperglycemia: It specifically targets the blood sugar spikes that occur after meals, making it an effective treatment for controlling postprandial hyperglycemia.\nBenefits of VOGLIGOLD 0.2\nEffective Postprandial Blood Sugar Control\nManages After-Meal Blood Sugar Levels: VOGLIGOLD 0.2 helps to manage and reduce the rise in blood sugar levels that occur after meals.\nComplementary Therapy: It can be used in combination with other antidiabetic medications such as metformin, sulfonylureas, or insulin to provide comprehensive glycemic control.\nAdditional Health Benefits\nWeight Neutral: Voglibose is generally weight neutral, making it a favorable option for patients concerned about weight gain associated with other diabetes medications.\nLow Risk of Hypoglycemia: When used alone, Voglibose has a low risk of causing hypoglycemia (low blood sugar), as it does not increase insulin secretion directly.\nHow to Use VOGLIGOLD 0.2\nDosage and Administration\nRecommended Dosage: The typical dosage of VOGLIGOLD 0.2 is one tablet taken three times a day, just before meals.\nAdministration: Take the tablet whole with a glass of water, just before starting your meal. This timing ensures that the medication works effectively by inhibiting the enzyme responsible for carbohydrate digestion.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VOGLIGOLD 0.2 regularly at the same times each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is important to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vogligold-0-2-133456",
"price": 89.0,
"discountamount": 26.7,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"rise",
"diet",
"Order",
"EMAIL",
"meals",
"glass",
"water",
"option",
"action",
"adults",
"timing",
"patients",
"Low Risk",
"exercise",
"readings",
"metformin",
"VOGLIGOLD",
"Voglibose",
"Mechanism",
"Guidelines",
"intestines",
"same times",
"one tablet",
"conversion",
"Optimal Use",
"weight gain",
"conjunction",
"Adjustments",
"combination",
"information",
"Introduction",
"Hypoglycemia",
"sterisonline",
"sterispharma",
"best results",
"simple sugars",
"CALL/WHATSAPP",
"Key Component",
"sulfonylureas",
"Weight Neutral",
"typical dosage",
"treatment plan",
"Administration",
"Consistent Use",
"small intestine",
"low blood sugar",
"insulin secretion",
"blood sugar spikes",
"Recommended Dosage",
"Regular monitoring",
"healthcare provider",
"effective treatment",
"complex carbohydrates",
"Complementary Therapy",
"carbohydrate digestion",
"Meal Blood Sugar Levels",
"Carbohydrate Absorption",
"alpha-glucosidase enzyme",
"type 2 diabetes mellitus",
"Postprandial Hyperglycemia",
"Additional Health Benefits",
"other diabetes medications",
"comprehensive glycemic control",
"other antidiabetic medications",
"postprandial blood glucose peaks",
"potent alpha-glucosidase inhibitor",
"Effective Postprandial Blood Sugar Control"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1515,
"imageuri": "https://productimages.withfloats.com/actual/667d34025e58b0758f70570b.png",
"tileimageuri": "https://productimages.withfloats.com/tile/667d34025e58b0758f70570b.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-07T08:47:49.18Z",
"updatedon": "2024-06-27T09:42:22.871Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/vogligold-0-2-/1515",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VOGLIGOLD 0.2 ",
"category": "DIABETIC RANGE",
"tags": [
"voglibose side effects",
"voglibose 0.2 mg side effects",
"voglibose 0.2mg dosage"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6662aa04db100e1fdc2dcb68",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VILDIABATE 100 ",
"description": "VILDIABATE 100 \nVildagliptin (100mg)\nVILDIABATE 100 is a medication designed to manage type 2 diabetes mellitus by targeting specific aspects of glucose regulation. It contains Vildagliptin, an oral antidiabetic agent that belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. Vildagliptin works by inhibiting the enzyme DPP-4, which is responsible for degrading incretin hormones like GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide).\n\nHere are key points about VILDIABATE 100:\n\nMechanism of Action: Vildagliptin acts by inhibiting DPP-4, thereby increasing the levels of GLP-1 and GIP. These hormones play crucial roles in glucose metabolism:\n\nGLP-1 stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner. It also inhibits glucagon secretion, reduces appetite, and slows gastric emptying.\nGIP enhances insulin release in response to meals, contributing to postprandial glucose control.\nBlood Sugar Control: By enhancing insulin secretion and reducing glucagon levels, VILDIABATE 100 helps lower blood sugar levels, especially after meals. This mechanism targets both fasting and postprandial hyperglycemia, contributing to overall glycemic control.\n\nDosage and Administration: VILDIABATE 100 is typically taken orally once daily, preferably with a meal to maximize its effects on postprandial glucose levels. The dosage may vary depending on individual needs and response to treatment. It's essential to follow your healthcare provider's instructions regarding dosage and timing.\n\nEfficacy and Safety: Clinical studies have demonstrated the efficacy of Vildagliptin in lowering HbA1c levels (a marker of long-term glucose control) and improving glycemic parameters. It is generally well-tolerated, with common side effects including headache, nasopharyngitis (inflammation of the nose and throat), and upper respiratory tract infections. Serious side effects are rare but may include pancreatitis or hypersensitivity reactions.\n\nCombination Therapy: VILDIABATE 100 may be prescribed as monotherapy or in combination with other antidiabetic medications such as metformin or sulfonylureas. Combining medications with different mechanisms of action can provide synergistic benefits in managing diabetes.\n\nMonitoring and Follow-Up: Regular monitoring of blood sugar levels, kidney function, and other relevant parameters is important during treatment with VILDIABATE 100. Your healthcare provider may adjust the dosage or add/modify other medications based on your response and individual needs.\n\nLifestyle Modifications: In addition to medication, lifestyle modifications such as a healthy diet, regular exercise, weight management, and avoiding tobacco and excessive alcohol intake are essential components of diabetes management.\n\nIn conclusion, VILDIABATE 100 containing Vildagliptin is an effective oral antidiabetic medication that helps regulate blood sugar levels in patients with type 2 diabetes. It acts by enhancing insulin secretion and reducing postprandial glucose levels, contributing to improved glycemic control. However, it should be used under medical supervision, and adherence to prescribed dosage and lifestyle recommendations is crucial for optimal diabetes management.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-100-133452\n\n\n\n\n\n",
"price": 275.0,
"discountamount": 82.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"GIP",
"nose",
"GLP-1",
"EMAIL",
"class",
"meals",
"Order",
"timing",
"throat",
"enzyme",
"Safety",
"Dosage",
"marker",
"tobacco",
"fasting",
"response",
"addition",
"appetite",
"headache",
"patients",
"Efficacy",
"metformin",
"Follow-Up",
"adherence",
"treatment",
"VILDIABATE",
"conclusion",
"key points",
"information",
"monotherapy",
"healthy diet",
"instructions",
"sterisonline",
"pancreatitis",
"inflammation",
"sterispharma",
"HbA1c levels",
"CALL/WHATSAPP",
"sulfonylureas",
"crucial roles",
"Administration",
"insulin release",
"nasopharyngitis",
"kidney function",
"glucagon levels",
"gastric emptying",
"specific aspects",
"Clinical studies",
"individual needs",
"regular exercise",
"other medications",
"Vildagliptin acts",
"incretin hormones",
"DPP-4) inhibitors",
"weight management",
"insulin secretion",
"glucose metabolism",
"glucose regulation",
"glucagon secretion",
"blood sugar levels",
"Regular monitoring",
"Combination Therapy",
"glycemic parameters",
"common side effects",
"Blood Sugar Control",
"medical supervision",
"healthcare provider",
"essential components",
"synergistic benefits",
"different mechanisms",
"Serious side effects",
"pancreatic beta cells",
"dipeptidyl peptidase-4",
"oral antidiabetic agent",
"Lifestyle Modifications",
"glucose-dependent manner",
"excessive alcohol intake",
"overall glycemic control",
"type 2 diabetes mellitus",
"lifestyle recommendations",
"other relevant parameters",
"long-term glucose control",
"hypersensitivity reactions",
"postprandial hyperglycemia",
"optimal diabetes management",
"postprandial glucose levels",
"postprandial glucose control",
"other antidiabetic medications",
"upper respiratory tract infections",
"effective oral antidiabetic medication",
"glucose-dependent insulinotropic peptide"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1491,
"imageuri": "https://productimages.withfloats.com/actual/6662aa0b364f23242470b3ca.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6662aa0b364f23242470b3ca.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-07T06:34:44.056Z",
"updatedon": "2024-06-28T11:58:50.164Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//vildiabate-100-/1491",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VILDIABATE 100 ",
"category": "DIABETIC RANGE",
"tags": [
"VILDIABATE 100",
"Vildagliptin (100mg)",
"Vildagliptin 100 mg uses",
"Vildagliptin 100 mg price",
"Vildagliptin 100 mg SR brand Name",
"Vildagliptin 100 mg brands in India",
"",
"Vildagliptin 100 mg generic medicine",
"Vildagliptin 100 mg side effects"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6661afd366170d1ff8cb4626",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TRIGLICLAGLAZE 60 ",
"description": "TRIGLICLAGLAZE 60 \nGliclazide 60mg (SR) Pioglitazone 15mg and Metformin HCL 500mg(SR)\nTRIGLICLAGLAZE 60 is a combination medication designed to effectively manage type 2 diabetes mellitus by addressing multiple aspects of glucose regulation. It combines three key components: Gliclazide 60mg (SR), Pioglitazone 15mg, and Metformin HCI 500mg (SR), each contributing to improved blood sugar control through distinct mechanisms of action.\n\nGliclazide 60mg (SR): Gliclazide is a sulfonylurea medication that stimulates the pancreas to release insulin. This insulin release helps lower blood sugar levels, especially after meals, by facilitating glucose uptake into cells.\n\nPioglitazone 15mg: Pioglitazone belongs to the thiazolidinedione class and works by improving insulin sensitivity in peripheral tissues such as muscle and fat cells. Enhanced insulin sensitivity allows for better utilization of glucose, reducing insulin resistance and promoting more efficient blood sugar management.\n\nMetformin HCI 500mg (SR): Metformin is a biguanide medication that primarily works by reducing glucose production in the liver and increasing insulin sensitivity in muscle cells. It also improves glucose uptake by cells and reduces the absorption of glucose from the digestive tract.\n\nKey Benefits of TRIGLICLAGLAZE 60:\nComprehensive Glucose Control: By combining Gliclazide (SR), Pioglitazone, and Metformin HCI (SR), TRIGLICLAGLAZE 60 offers comprehensive control over blood sugar levels throughout the day.\n\nStimulates Insulin Release: Gliclazide's action in stimulating insulin release from the pancreas helps manage postprandial (after-meal) glucose spikes, contributing to overall glucose control.\n\nImproves Insulin Sensitivity: Pioglitazone enhances insulin sensitivity in tissues, leading to better glucose uptake and utilization by cells. This helps reduce insulin resistance, a common feature of type 2 diabetes.\n\nReduces Glucose Production: Metformin HCI lowers glucose production in the liver and improves insulin action in muscle cells, leading to lower fasting blood sugar levels and enhanced glucose utilization.\n\nExtended Release Formulation: The sustained-release formulations of Gliclazide and Metformin ensure a gradual and prolonged release of the medications, providing consistent blood sugar control and minimizing the risk of hypoglycemia or hyperglycemia.\n\nDosage and Administration:\nTRIGLICLAGLAZE 60 is typically taken orally once or twice daily, with meals to reduce gastrointestinal side effects.\nDosage adjustments may be required based on blood sugar levels and individual response to treatment. Follow your healthcare provider's instructions.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/trigliclaglaze-60-134279",
"price": 155.0,
"discountamount": 47.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"SR",
"day",
"risk",
"meals",
"Order",
"liver",
"EMAIL",
"gradual",
"fasting",
"pancreas",
"Enhanced",
"treatment",
"fat cells",
"absorption",
"information",
"medications",
"muscle cells",
"Pioglitazone",
"sterisonline",
"Key Benefits",
"hypoglycemia",
"instructions",
"sterispharma",
"postprandial",
"hyperglycemia",
"CALL/WHATSAPP",
"Metformin HCL",
"Metformin HCI",
"Administration",
"glucose uptake",
"TRIGLICLAGLAZE",
"common feature",
"glucose spikes",
"insulin action",
"insulin release",
"Gliclazide 60mg",
"digestive tract",
"multiple aspects",
"prolonged release",
"Dosage adjustments",
"peripheral tissues",
"blood sugar levels",
"glucose production",
"insulin resistance",
"glucose regulation",
"distinct mechanisms",
"healthcare provider",
"individual response",
"glucose utilization",
"insulin sensitivity",
"three key components",
"biguanide medication",
"comprehensive control",
"combination medication",
"sulfonylurea medication",
"thiazolidinedione class",
"overall glucose control",
"type 2 diabetes mellitus",
"Extended Release Formulation",
"Comprehensive Glucose Control",
"gastrointestinal side effects",
"sustained-release formulations",
"consistent blood sugar control",
"efficient blood sugar management"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1485,
"imageuri": "https://productimages.withfloats.com/actual/6661afd7f21358d53af3cd71.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6661afd7f21358d53af3cd71.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-06T12:47:15.16Z",
"updatedon": "2024-06-28T12:12:27Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/trigliclaglaze-60-/1485",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TRIGLICLAGLAZE 60 ",
"category": "DIABETIC RANGE",
"tags": [
"TRIGLICLAGLAZE 60",
"Gliclazide 60mg (SR)",
"Pioglitazone 15mg",
"Metformin HCL 500mg(SR)",
"Metformin SR 500mg uses",
"Metformin SR 500 price",
"Metformin SR 500 side effects"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}